Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 8/2006

01-08-2006 | Contrast Media

Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines

Authors: Henrik S. Thomsen, Sameh K. Morcos

Published in: European Radiology | Issue 8/2006

Login to get access

Abstract

The interest in contrast-medium-induced nephropathy has increased considerably during the last few years. Various guidelines regarding identifying patients at risk and measures to reduce the incidence of this complication have been proposed. The aim of this review was to analyse whether there is some consistency amongst these guidelines. A Medline search for the keyword “contrast medium induced nephropathy” during the period from the beginning of 2003 through the end of September 2005 was carried out. Only papers in English were reviewed. Thirteen guidelines were identified. Inconsistency was observed regarding advise on the prophylactic use of drugs and the isoosmolar dimer to reduce the incidence of contrast-medium-induced nephropathy. Consistency was found in relation to the importance of hydration, cessation of intake of nephrotoxic drugs and administration of the lowest possible dose of contrast medium. No new consensus has been observed in comparison to the European Society for Urogenital Radiology (ESUR) guidelines, which were published in 1999.
Literature
1.
Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA (2000) Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216:481–484PubMed
2.
Choyke PL, Cady K, DePollar SL, Austin H (1998) Determination of serum creatinine prior to iodinated contrast media: is it needed in all patients? Tech Urol 4:65–69PubMed
3.
Olsen JC, Salomon B (1996) Utility of the creatinine prior to intravenous contrast studies in the emergency department. J Emerg Med 14:543–546PubMedCrossRef
4.
The Committee on Drugs and Contrast Media of the American College of Radiology (2005) ACR manual on contrast media. American College of Radiology, 1981 Preston White Drive, Reston, VA 20191–4378, USA
5.
Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) In which patients should serum-creatinine be measured before contrast medium administration? Eur Radiol 15:749–756PubMedCrossRef
6.
Lin J, Bonventre JV (2005) Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 14:105–110PubMedCrossRef
7.
Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed
8.
Bartholomew BA, Harjai KJ, Dukkipati S et al (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519PubMedCrossRef
9.
Gleeson T, Bulugahapitiya S (2004) Contrast induced nephropathy. AJR Am J Roentgenol 183:1673–1689PubMed
10.
Gleeson TG, O’Dwyer J, Bulugahapitiya S, Foley D (2004) Contrast-induced nephropathy. Br J Cardiol 11:AIC 53–AIC 61
11.
Erdogan A, Davidson CJ (2003) Recent clinical trials of iodixanol. Rev Cardiovasc Med 4(Suppl 5):S43–S50PubMed
12.
Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 44:327–337PubMedCrossRef
13.
14.
Briguori C, Airoldi F, Colombo A (2005) Prevention of contrast nephropathy. Cardiol Int Autumn, 84–90
15.
Goldenberg I, Matetzky S (2005) Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172:1461–1471PubMed
16.
Weisbord SD, Palevsky PM (2005) Radiocontrast-induced acute renal failure. J Intensive Care Med 20:63–75PubMedCrossRef
17.
Morcos SK, Thomsen HS, Webb JAW and members of contrast media safety committee of the European Society of Urogenital Radiology (ESUR) (1999) Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613PubMedCrossRef
18.
Merten GJ, Burgess WP, Gary LV et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291:2328–2334PubMedCrossRef
19.
Bakris GL, Lass N, Gabaer AO, Jones JD, Burnette JC Jr (1990) Radiocontrast medium-induced declines in renal function. A role for oxygen free radicals. Am J Physiol 175:57–60
20.
Atkins JL (1986) Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron 44:70–76PubMedCrossRef
21.
Morcos SK (2005) Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol 16:13–23PubMed
22.
Thomsen HS (2006) Reducing the risk of contrast media induced nephrotoxicity. In: Thomsen HS (ed) Contrast media: safety issues and ESUR Guidelines. Springer, Heidelberg Berlin New York, pp 53–55CrossRef
23.
Aspelin P, Aubry P, Fransson S-G et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499PubMedCrossRef
24.
Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41:2114–2118PubMedCrossRef
25.
Boccolandro F, Amhad M, Smalling RW, Sdringola S (2003) Oral acetylcysteine does not protect protect renal function from moderate to high doses of intravenous radiographic contrast. Cathet Cardiovasc Interv 58:336–341CrossRef
26.
Stone GW, McCullough PA, Tumlin JA et al (2003) CONTRAST investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284–2291PubMedCrossRef
27.
Briguori C, Colombo A, Airoldi F et al (2005) Nephrotoxocity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int 68:2250–2255PubMedCrossRef
28.
Solomon R (2005) The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney Int 68:2256–2263PubMedCrossRef
29.
Bettmann MA (2005) Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 20(suppl 1):i2–i7
30.
Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407–410PubMedCrossRef
31.
Morcos SK, Thomsen HS, Webb JAW, Members of the Contrast Media Safety Committee of European Society of Urogenital Radiology (2002) Dialysis and contrast media. Eur Radiol 12:3026–3030PubMed
32.
Barrett BJ, Parfrey PS (2006) Preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386PubMedCrossRef
33.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analysis. Br Med J 327:557–560CrossRef
Metadata
Title
Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines
Authors
Henrik S. Thomsen
Sameh K. Morcos
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
European Radiology / Issue 8/2006
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0223-4

Other articles of this Issue 8/2006

European Radiology 8/2006 Go to the issue

Head and Neck

Pathologic-sonographic correlation in temporomandibular joint pathology

Breast

MRI-guided needle localization of suspicious breast lesions: results of a freehand technique

Pediatric

Value of virtual tracheobronchoscopy and bronchography from 16-slice multidetector-row spiral computed tomography for assessment of suspected tracheobronchial stenosis in children

Cardiac

31P-MR spectroscopic imaging in hypertensive heart disease

Experimental

Evolving technology in bipolar perfused radiofrequency ablation: assessment of efficacy, predictability and safety in a pig liver model

Head and Neck

Comparison of different patient positioning strategies to minimize shoulder girdle artifacts in head and neck CT